These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21726161)

  • 1. Almotriptan for menstrually related migraine.
    Bussone G; Allais G; Castagnoli Gabellari I; Benedetto C
    Expert Opin Pharmacother; 2011 Aug; 12(12):1933-43. PubMed ID: 21726161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of almotriptan in menstrual migraine: a comment.
    Lionetto L; Fiorillo M; Martelletti P
    Expert Opin Pharmacother; 2011 Oct; 12(15):2279-81. PubMed ID: 21916785
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of almotriptan for the treatment of migraines.
    Negro A; Lionetto L; D'Alonzo L; Casolla B; Marsibilio F; Vignaroli G; Simmaco M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2013 May; 9(5):637-44. PubMed ID: 23570251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiological and pharmacological basis of current drug treatment of migraine headache.
    Reddy DS
    Expert Rev Clin Pharmacol; 2013 May; 6(3):271-88. PubMed ID: 23656340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment.
    Silberstein S; Patel S
    Expert Opin Pharmacother; 2014 Oct; 15(14):2063-70. PubMed ID: 25100506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.
    Allais G; Acuto G; Benedetto C; D'Andrea G; Grazzi L; Manzoni GC; Moschiano F; d'Onofrio F; Valguarnera F; Bussone G
    Neurol Sci; 2010 Jun; 31 Suppl 1(Suppl 1):S115-9. PubMed ID: 20464599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
    Goadsby PJ; Zanchin G; Geraud G; de Klippel N; Diaz-Insa S; Gobel H; Cunha L; Ivanoff N; Falques M; Fortea J
    Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral almotriptan: practical uses in the acute treatment of migraine.
    Dowson AJ
    Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Almotriptan for the treatment of acute migraine: a review of early intervention trials.
    Antonaci F; De Cillis I; Cuzzoni MG; Allena M
    Expert Rev Neurother; 2010 Mar; 10(3):351-64. PubMed ID: 20187858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
    Allais G; Bussone G; D'Andrea G; Moschiano F; d'Onofrio F; Valguarnera F; Manzoni GC; Grazzi L; Allais R; Benedetto C; Acuto G
    Cephalalgia; 2011 Jan; 31(2):144-51. PubMed ID: 20660540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study.
    Facchinetti F; Allais G; Nappi RE; Gabellari IC; Di Renzo GC; Genazzani AR; Bellafronte M; Roncolato M; Benedetto C
    Gynecol Endocrinol; 2010 Oct; 26(10):773-9. PubMed ID: 20528213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
    Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
    Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
    Diener HC
    Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE
    Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almotriptan in triptan-naïve patients: new evidence of benefits.
    Pascual J
    Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of menstrually related and non-menstrual migraine.
    Güven B; Güven H; Çomoğlu S
    Acta Neurol Belg; 2017 Sep; 117(3):671-676. PubMed ID: 28560689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.